The success of any company relies on the experience, energy, and talent of those spearheading the venture. It also requires a deep source of knowledge and experience from which the management team can draw. BioFactura has assembled a team of Directors, whose range of experience includes Science, Medicine, Manufacturing, Business, Finance, and Management. The Board of Directors work closely with the management team to ensure BioFactura’s growth and success.
Board of Directors
Board of Directors
Jeffrey Hausfeld M.D., M.B.A., F.A.C.S., Chairman
Chief Medical Officer
Dr. Hausfeld serves as Chairman of the Board of BioFactura as well as Chief Medical Officer. He provides strategic perspectives and plans for the targeted deployment of resources, the designing of clinical trials, expanding business development within the Biotech and business communities, as well as monitoring financial and governance aspects.
Darryl Sampey, Ph.D., Director
President and CEO
Darryl Sampey co-founded BioFactura in 2004 and as President and CEO manages all strategic and scientific endeavors of the Company including partnership/alliance building, intellectual property maintenance, contract research and development, platform technology programs, and biopharmaceutical product development.
Alex DeSeabra, Director
Director and Co-founder
Alexandre DeSeabra co-founded BioFactura and has over 25 years of experience in biotechnology. From bench-scale research to large-scale manufacturing, Mr. DeSeabra has worked with both microbial and mammalian systems producing a broad spectrum of biologics.
Dominic Eisinger, Ph.D., Director
Director
Dr. Dominic Eisinger is a biotechnology chief commercial executive and entrepreneur who combines his
scientific expertise with business, market, and customer insights to achieve sustained commercial impact and
value.